Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer

Jurriaan Brouwer-Visser; Jiyeon Lee; KellyAnne McCullagh; Maria J. Cossio; Yanhua Wang; Gloria S. Huang

doi:10.1371/journal.pone.0100165

Loading metrics

Open Access

Peer-reviewed

Research Article

Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer

Jurriaan Brouwer-Visser,

Affiliation Department of Obstetrics and Gynecology & Women’s Health (Division of Gynecologic Oncology), Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
⨯
Jiyeon Lee,

Affiliation Department of Obstetrics and Gynecology & Women’s Health (Division of Gynecologic Oncology), Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
⨯
KellyAnne McCullagh,

Affiliation Department of Obstetrics and Gynecology & Women’s Health (Division of Gynecologic Oncology), Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
⨯
Maria J. Cossio,

Affiliation Department of Obstetrics and Gynecology & Women’s Health (Division of Gynecologic Oncology), Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
⨯
Yanhua Wang,

Affiliation Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
⨯
Gloria S. Huang

* E-mail: ghuang@montefiore.org

Affiliations Department of Obstetrics and Gynecology & Women’s Health (Division of Gynecologic Oncology), Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America, Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States of America, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯

Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer

Jurriaan Brouwer-Visser,
Jiyeon Lee,
KellyAnne McCullagh,
Maria J. Cossio,
Yanhua Wang,
Gloria S. Huang

Published: June 16, 2014
https://doi.org/10.1371/journal.pone.0100165

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.